Specifically, some dying tumor cells release multiple danger signals or damage-associated molecular patterns (DAMPs), including high mobility group protein B1 (HMGB1), calreticulin and ATP, which dominantly represent immunogenic features and may contribute to the immunotherapy [6, 9]. The gene discussed is CALR; the disease is neoplasm.